Close Menu

NEW YORK – October, historically often a turbulent month for the stock market, was choppy for some diagnostics companies, even as the 360Dx Index remained relatively unchanged month over month.  

The index increased a fraction of 1 percent month over month in October, after sliding nearly 4 percent in September. Of the 29 companies in the index, 18 firms' stocks were down, while 11 companies' share prices increased.

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Don't have a 360Dx or GenomeWeb account?
Register for Free.